By optimizing the laboratory process, we were able to significantly reduce the failure rate of the Harmony® test. An NIPT without a result often causes uncertainty among pregnant women and in many cases leads to further – usually invasive – clarification. A low rate of non-evaluable tests is therefore an important quality criteria for a […]

In a recent study, published in February 2023 in Prenatal Diagnosis, we investigated in collaboration with Prof. Kagan (University Women’s Hospital Tuebingen) the correlation between the screen-positive rate and the fetal fraction (proportion of cell-free fetal DNA) when screening for microdeletion 22q11.2 (DiGeorge syndrome). We analyzed own data from more than 50,000 singleton pregnancies. The

Discontinuation of the test option microdeletion 22q11.2 (DiGeorge syndrome) 28. March 2022 We have been analyzing the 22q11.2 microdeletion 22q11.2 (DiGeorge syndrome) as part of the Harmony® Test since July 2018. We now evaluated the data from more than 50000 cases. The evaluation of the data shows that of the cases tested positive for DiGeorge syndrome